Literature DB >> 8698871

Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.

R Sgonc1, M S Gruschwitz, H Dietrich, H Recheis, M E Gershwin, G Wick.   

Abstract

The mechanism that may cause degenerative fibrotic skin lesions was studied in situ using skin biopsies from patients with systemic sclerosis (SSc), localized scleroderma, or keloids, and at the initial disease stage in the University of California at Davis (UCD) lines 200/206 chickens, which develop a hereditary systemic connective tissue disease resembling human SSc and permit study of disease stages not accessible in humans. Frozen skin sections were analyzed simultaneously for apoptosis by terminal deoxynucleotidyl transferase-mediated FITC-dUTP nick end labeling and indirect immunofluorescence staining of cell markers with tetramethylrhodamine isothiocyanate conjugates. The results showed that endothelial cells are clearly the first cells to undergo apoptosis in the skin of UCD-200/206 chickens, a process that seems to be induced by anti-endothelial cell antibodies. In human fibrotic skin diseases, apoptotic endothelial cells could only be detected in early inflammatory disease stages of SSc and localized scleroderma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698871      PMCID: PMC507489          DOI: 10.1172/JCI118851

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Housing, breeding and selecting chickens of the Obese strain (OS) with spontaneous autoimmune thyroiditis.

Authors:  H M Dietrich
Journal:  Lab Anim       Date:  1989-10       Impact factor: 2.471

2.  A modified scleroderma skin scoring method.

Authors:  M B Kahaleh; G L Sultany; E A Smith; J E Huffstutter; C B Loadholt; E C LeRoy
Journal:  Clin Exp Rheumatol       Date:  1986 Oct-Dec       Impact factor: 4.473

3.  The effects of scleroderma serum on human microvascular endothelial cells. Induction of antibody-dependent cellular cytotoxicity.

Authors:  R M Marks; M Czerniecki; B S Andrews; R Penny
Journal:  Arthritis Rheum       Date:  1988-12

4.  Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

Authors:  C A Penning; J Cunningham; M A French; G Harrison; N R Rowell; P Hughes
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

5.  Identification of T cells in early dermal lymphocytic infiltrates in avian scleroderma.

Authors:  J van de Water; L Haapanen; R Boyd; H Abplanalp; M E Gershwin
Journal:  Arthritis Rheum       Date:  1989-08

6.  Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases.

Authors:  J Rosenbaum; B E Pottinger; P Woo; C M Black; S Loizou; M A Byron; J D Pearson
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

Review 7.  Systemic scleroderma. Clinical and pathophysiologic aspects.

Authors:  T Krieg; M Meurer
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

8.  Serial observations and definition of mononuclear cell infiltrates in avian scleroderma, an inherited fibrotic disease of chickens.

Authors:  J van de Water; M E Gershwin; H Abplanalp; G Wick; K von der Mark
Journal:  Arthritis Rheum       Date:  1984-07

9.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  A Vismara; P L Meroni; A Tincani; E N Harris; W Barcellini; A Brucato; M Khamashta; G R Hughes; C Zanussi; G Balestrieri
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

10.  Animal model of human disease. Avian scleroderma. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis.

Authors:  J van de Water; M E Gershwin
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

View more
  87 in total

Review 1.  Anti-endothelial cell antibodies in systemic sclerosis.

Authors:  Y Renaudineau; R Revelen; Y Levy; K Salojin; B Gilburg; Y Shoenfeld; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

Review 2.  Animal models for scleroderma: an update.

Authors:  Yan Zhang; Anita C Gilliam
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

3.  Vascular leak is a central feature in the pathogenesis of systemic sclerosis.

Authors:  Tracy M Frech; Monica P Revelo; Stavros G Drakos; Maureen A Murtaugh; Boaz A Markewitz; Allen D Sawitzke; Dean Y Li
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

Review 4.  Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.

Authors:  Maria Trojanowska
Journal:  Nat Rev Rheumatol       Date:  2010-06-29       Impact factor: 20.543

Review 5.  A unifying hypothesis for scleroderma: identifying a target cell for scleroderma.

Authors:  William M Mahoney; Jo Nadine Fleming; Stephen M Schwartz
Journal:  Curr Rheumatol Rep       Date:  2011-02       Impact factor: 4.592

Review 6.  [Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

Authors:  C Sunderkötter; G Riemekasten
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

7.  High expression of CD40 on skin fibroblasts from patients with systemic sclerosis.

Authors:  Jae-Bum Jun; Tae-Hwan Kim; Young-In Na; Dae-Hyun Yoo
Journal:  Rheumatol Int       Date:  2007-08-09       Impact factor: 2.631

8.  Linear Scleroderma and Primary Sclerosing Cholangitis: An Undescribed Association.

Authors:  Iñigo Navarro Fernández; Susana Armesto Alonso; Carlos Duran Vian; L Reguero Del Cura; Carmen González-Vela; Marcos González-López
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

9.  Extracellular Vesicles: Evolving Contributors in Autoimmunity.

Authors:  Stergios Katsiougiannis
Journal:  For Immunopathol Dis Therap       Date:  2015

Review 10.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.